STINISSEN, Piet

Email Alert RSS Feed

Profile

Full Name
STINISSEN, Piet
Email
piet.stinissen@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Author:  HELLINGS, Niels
Date Issued:  [2001 TO 2009]

Results 21-40 of 58 (Search time: 0.008 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
212008Mesenchymal stromal cells derived from bone marrow and Wharton's Jelly as potential sources for cell-based therapies in multiple sclerosisTHEUNISSEN, Evi; MOREELS, Marjan; Ponsaerts, Peter; LAMBRICHTS, Ivo; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
222008Neuroprotective and immunomodulatory effects of leukemia inhibitory factor during neuroinflammatory responses in multiple sclerosisSlaets, Helena; HENDRIKS, Jerome; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
232008Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3SLAETS, Leen; DUMONT, Debora; VANDERLOCHT, Joris; NOBEN, Jean-Paul; Leprince, P.; ROBBEN, Johan; HENDRIKS, Jerome; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
242007Leukemia inhibitory factor is immunomodulatory and is secreted by activated macrophages during myelin uptakeHENDRIKS, Jerome; CARMANS, Sofie; SLAETS, Leen; de Vries, Elga; Dijkstra, Christine; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
252007Leukemia inhibitory factor-mediated protection of oligodendrocytes: implications for multiple sclerosisSLAETS, Leen; DUMONT, Debora; VANDERLOCHT, Joris; Leprince, P.; ROBBEN, Johan; HENDRIKS, Jerome; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
262007CD4(+)CD28(null) T cells in autoimmune disease: Pathogenic features and decreased susceptibility to immunoregulationTHEWISSEN, Marielle; SOMERS, Veerle; HELLINGS, Niels; FRAUSSEN, Judith; Damoiseaux, Jan; STINISSEN, PietJournal ContributionA1
272007Characterization of mature rat oligodendrocytes: a proteomic approachDUMONT, Debora; NOBEN, Jean-Paul; MOREELS, Marjan; VANDERLOCHT, Joris; HELLINGS, Niels; VANDENABEELE, Frank; LAMBRICHTS, Ivo; STINISSEN, Piet; ROBBEN, JohanJournal ContributionA1
282007A CFSE based assay for measuring CD4(+)CD25(+) regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responsesVENKEN, Koen; THEWISSEN, Marielle; HELLINGS, Niels; SOMERS, Veerle; HENSEN, Karen; STINISSEN, Piet; RUMMENS, Jean-LucJournal ContributionA1
292007The ambivalent nature of T-cell infiltration in the central nervous system of patients with multiple sclerosisVANDERLOCHT, Joris; HELLINGS, Niels; HENDRIKS, Jerome; STINISSEN, PietJournal ContributionA1
302007Immune mediated protection in multiple sclerosis: A role for neurokines in oligodendrocyte survival and macrophage modulationHELLINGS, Niels; HENDRIKS, Jerome; CARMANS, Sofie; SLAETS, Leen; DUMONT, Debora; VANDERLOCHT, Joris; STINISSEN, PietJournal ContributionM
312007Reduced number of blood circulating foxp3+CD25highCD4+regulatory T cells and a decreased foxp3 expression at the single-cell level in patients with relapsing-remitting multiple sclerosisVENKEN, Koen; HELLINGS, Niels; SOMERS, Veerle; Meuwissen, Pieter; THEWISSEN, Marielle; HENSEN, Karen; RUMMENS, Jean-Luc; STINISSEN, PietJournal ContributionM
322007Compromised CD4+CD25Hi regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3 positive cells and a reduced FOXP3 expression at the single-cell levelVENKEN, Koen; HELLINGS, Niels; THEWISSEN, Marielle; SOMERS, Veerle; HENSEN, Karen; RUMMENS, Jean-Luc; MEDAER, Rob; Hupperts, R.; STINISSEN, PietJournal ContributionM
332007CD4+CD28null T cells in autoimmune disease: Pathogenic features and decreased susceptibility to immunoregulationTHEWISSEN, Marielle; SOMERS, Veerle; HELLINGS, Niels; STINISSEN, Piet; VENKEN, KoenJournal ContributionM
342006Current trends in multiple sclerosis research: an update on pathogenic conceptsVANDERLOCHT, Joris; HELLINGS, Niels; HENDRIKS, Jerome; STINISSEN, PietJournal ContributionA1
352006No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosisVANDERLOCHT, Joris; BURZYKOWSKI, Tomasz; SOMERS, Veerle; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
362006Effects of IFN-beta, leptin and sinivastatin on LIF secretion by T lymphocytes of MS patients and healthy controlsVANDERLOCHT, Joris; HENDRIKS, Jerome; VENKEN, Koen; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
372006Influence of leukaemia inhibitory factor on macrophage function in vitro and during experimental autoimmune encephalomyelitisHENDRIKS, Jerome; HELLINGS, Niels; VANDERLOCHT, Joris; STINISSEN, PietJournal ContributionM
382006T-cell vaccination in MS with CSF-derived activated CD4(+) T-cells: Results of a placebo-controlled trialSTINISSEN, Piet; MEDAER, Rob; HELLINGS, Niels; Barkhof, F.; RAUS, JefJournal ContributionM
392006Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controlsVANDERLOCHT, Joris; HENDRIKS, Jerome; VENKEN, Koen; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
402006Secondary progressive in contrast to relapsing - Remitting multiple sclerosis patients show a normal CD4(+)CD25(+) regulatory T cell function and FOXP3 expressionVENKEN, Koen; HELLINGS, Niels; HENSEN, Karen; RUMMENS, Jean-Luc; MEDAER, Rob; D'hooghe, MB; Dubois, B; RAUS, Jef; STINISSEN, PietJournal ContributionM
show all